Reimagining Alzheimer’s care: Harnessing subcutaneous therapies and early diagnostic innovation to transform patient lives
touchPANEL DISCUSSION for touchNEUROLOGY
Listen to three leading experts discussing the recent advances in timely, biomarker-guided diagnosis and how current and emerging intravenous and subcutaneous disease-modifying therapies may impact clinical practice in the future and enable treatment personalization based on the underlying pathology of Alzheimer’s disease
The experts
Dr Soo Borson, Keck USC School of Medicine, Los Angeles, CA, USA
Dr Clifford Singer, Northern Light Acadia Hospital, Bangor, ME, USA
Dr Frederick Ketchum, University of Wisconsin-Madison, Madison, WI, USA
This touchPODCAST…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.